Free Stock & ETF Comparisons

Compare Vanguard International Dividend Appreciation ETF and Vanguard FTSE All-World ex-US ETF by dividend growth screen, emerging market inclusion, yield, and international equity return potential.

Compare Schwab International Dividend Equity ETF and Vanguard International High Dividend Yield ETF by yield, country allocation, dividend growth screen, and which international income ETF is better.

Compare Vanguard FTSE All-World ex-US Small-Cap ETF and Avantis International Small Cap Value ETF by value/profitability factor exposure, expected return premium, and expense ratio.

Compare Thermo Fisher Scientific and Danaher by lab instrument and reagent revenue, bioproduction recovery, M&A track record, free cash flow compounding, and valuation.

Compare Danaher and West Pharmaceutical Services by lab tools vs drug containment revenue, biopharma customer mix, GLP-1 drug packaging tailwind, and long-term compounder quality.

Compare Illumina and Pacific Biosciences by DNA sequencing market share, short-read vs long-read accuracy, instrument installed base, and genomics precision medicine revenue.

Compare Becton Dickinson and Abbott Laboratories by medical device vs diagnostics revenue mix, diabetes CGM competition, biosurgery market, dividend growth, and long-term value.

Compare Hologic and Illumina by molecular diagnostics revenue durability, cervical cancer screening adoption, genomic sequencing market penetration, and post-COVID base effect.

Compare Charles River Laboratories and IQVIA by preclinical contract research revenue, clinical data analytics ARR, biopharma customer mix, and post-biotech funding recovery timing.

Compare Masimo and Intuitive Surgical by patient monitoring sensor revenue, da Vinci procedure volume, capital equipment cycle, and consumer health pivots vs pure medical device revenue.

Compare Arrowhead Pharmaceuticals and Moderna by RNA drug platform approach, cardiometabolic pipeline progress, clinical trial risk, cash runway, and emerging biologic revenue.

Compare Vertex Pharmaceuticals and CRISPR Therapeutics by Casgevy gene editing revenue launch, CF franchise durability, pipeline beyond approved therapies, and biotech valuation.

Compare SPDR S&P Regional Banking ETF and Financial Select Sector SPDR by rate cycle sensitivity, big-bank vs community-bank risk, SVB crisis aftermath, and income potential.

Compare MetLife and Prudential Financial by group benefits vs retirement products revenue, interest rate sensitivity of reserves, dividend yield, buyback pace, and long-term insurance value.

Compare Chubb and Allstate by commercial property-casualty underwriting quality, personal auto loss ratio recovery, investment income, combined ratio, and relative valuation.

Compare Berkshire Hathaway and AIG by GEICO vs commercial insurance profitability, float investment return, book value growth, and which insurance-heavy stock offers better risk-adjusted returns.

Compare Voya Financial and Lincoln National by variable annuity guarantee exposure, pension risk transfer revenue, capital adequacy post-rate-move, dividend sustainability, and analyst upside.

Compare Ares Management and Blackstone by credit vs private equity and real estate AUM mix, fee-related earnings growth, retail distribution expansion, and alternative asset manager valuation.

Compare KKR and Ares Management by buyout fund performance, private credit direct lending AUM, insurance capital deployment, FRE growth, and relative valuation.

Compare Charles Schwab and Morgan Stanley by wealth management AUM, net interest income sensitivity, E*Trade integration, deposit pressure timeline, and which financial services stock offers more upside.

Compare T. Rowe Price and BlackRock by active fund outflows vs ETF inflow growth, fee compression pressure, ETF product expansion, dividend yield, and which asset manager adapts better.

Compare Invesco and Franklin Templeton by active vs ETF AUM mix, passive ETF business scale, alternative asset pivot, dividend yield, and which asset manager has the better recovery story.

Compare Freeport-McMoRan and Vale by copper vs iron ore price leverage, AI and EV electrification demand, EM political risk, dividend policy, and which metal miner is the better investment.

Compare Cleveland-Cliffs and Nucor by EAF efficiency advantage, automotive steel contracts, US tariff protection leverage, dividend track record, and which US steelmaker is the better pick.

Compare Packaging Corporation of America and International Paper by containerboard price cycle, e-commerce corrugated demand, DS Smith acquisition impact, and dividend sustainability.

Compare CF Industries and Mosaic by nitrogen vs potash fertilizer price cycles, blue/green ammonia energy transition optionality, dividend policy, and agricultural commodity exposure.

Compare Air Products and Linde by megaproject hydrogen energy investment, clean energy transition strategy, project backlog, return on capital, and relative valuation.

Compare PPG Industries and Sherwin-Williams by industrial vs architectural coatings mix, pricing power through raw material inflation, paint store network, and relative valuation.

Compare Dow and LyondellBasell by polyethylene vs polypropylene price exposure, packaging demand recovery, dividend sustainability from cycle trough, and long-term chemical value.

Compare Amcor and Ball Corporation by flexible vs rigid packaging market, beverage can demand cycle, sustainability-driven portfolio shift, dividend yield, and relative valuation.

Compare Wheaton Precious Metals and Barrick Gold by royalty/streaming margin vs production-cost risk, silver vs gold exposure, capital allocation discipline, and which gold investment wins.

Compare Newmont and Barrick Gold by all-in sustaining cost, mine reserve life, copper byproduct revenue, acquisition integration (Newcrest), dividend, and which senior gold miner wins.

Compare Marriott International and Hilton Worldwide by loyalty program member count, RevPAR recovery, asset-light franchise model, fee revenue growth, and relative valuation.

Compare Hilton and Hyatt Hotels by luxury vs full-service mix, unit growth pace, Honors vs World of Hyatt loyalty size, free cash flow, and which hotel brand compounder is the better buy.

Compare Expedia and Booking Holdings by hotel nights booked, Vrbo alternative accommodation growth, European vs global OTA share, margin profile, and relative valuation.

Compare Royal Caribbean and Carnival Corporation by onboard spending per passenger, private destination revenue, premium brand vs volume strategy, debt paydown pace, and analyst upside.

Compare Norwegian Cruise Line Holdings and Royal Caribbean by luxury/premium mix, private island investment, yield growth, leverage ratio, and which cruise line offers more upside.

Compare Delta Air Lines and United Airlines by business travel recovery, transatlantic capacity, loyalty program revenue, fleet modernization, labor costs, and analyst upside.

Compare American Airlines and Delta by debt levels, network strength, credit card co-brand revenue, operational reliability, and which airline's risk-reward is more attractive.

Compare Southwest Airlines and Delta Air Lines by point-to-point vs hub-and-spoke model, seat configuration change impact, corporate travel vs leisure mix, and recovery trajectory.

Compare MGM Resorts and Wynn Resorts by Macau VIP recovery, digital gaming growth, Las Vegas RevPAR, room rate premium, BetMGM vs digital absence, and valuation.

Compare Las Vegas Sands and Wynn Resorts by Macau mass gaming floor revenue, Singapore integrated resort EBITDA, Cotai concession renewal, and which Macau casino stock wins.

Compare Disney and Netflix by streaming subscriber and ARPU growth, content library depth, theme park profitability, sports rights value (ESPN), and long-term media stock value.

Compare Fox Corporation and Disney by Fox News advertising revenue, Tubi AVOD growth, sports rights value, theme park earnings vs news franchise, and relative valuation.

Compare Match Group (Tinder, Hinge) and Bumble by payer conversion rate, ARPU growth, AI matchmaking features, international expansion, and recovery from dating app saturation.

Compare Reddit and Snap by daily active user monetisation, AI data licensing revenue (Reddit), AR glasses strategy (Snap), ad revenue per user, and path to sustained profitability.

Compare Pinterest and Snap by social commerce conversion, Amazon advertising partnership impact, daily user engagement, ad revenue recovery, and which social media stock has more near-term upside.

Compare Yelp and TripAdvisor by monetised interactions, advertiser ROI, AI-driven review quality, Viator experiences marketplace growth, and which local/travel review platform wins.